Extrahepatic Bile Duct Adenocarcinoma

Extrahepatic Bile Duct Adenocarcinoma, also known as adenocarcinoma of the extrahepatic bile duct, is related to papillary extrahepatic bile duct adenocarcinoma and bile duct adenocarcinoma, and has symptoms including abdominal pain, icterus and nausea. An important gene associated with Extrahepatic Bile Duct Adenocarcinoma is MIR556 (MicroRNA 556). The drugs Sorafenib and Trastuzumab have been mentioned in the context of this disorder. Affiliated tissues include liver and lymph node, and related phenotype is Increased shRNA abundance (Z-score > 2).